Drugs / Chirorab
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05667974 Comparator | Sep 2023 → Mar 2024 | rabies | Yisheng Biopharma (Singapore) Pte. Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chirorab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05667974 ↗ |
| Modality | Vaccine | “rabies vaccine comparator” NCT05667974 ↗ |
| Route | Intramuscular | “via IM administration” NCT05667974 ↗ |